BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 25, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Ligand, Pfizer sales and marketing update

Pfizer launched Viviant bazedoxifene in Japan to treat postmenopausal osteoporosis. The selective estrogen receptor modulator (SERM) is marketed as ...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >